171 related articles for article (PubMed ID: 37256771)
21. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
22. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
24. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
[No Abstract] [Full Text] [Related]
25. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
26. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species / photothermal therapy dual-triggered biomimetic gold nanocages nanoplatform for combination cancer therapy via ferroptosis and tumor-associated macrophage repolarization mechanism.
Wei Y; Wang Z; Yang J; Xu R; Deng H; Ma S; Fang T; Zhang J; Shen Q
J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1950-1965. PubMed ID: 34695762
[TBL] [Abstract][Full Text] [Related]
28. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
29. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy.
Liang Y; Zhang L; Peng C; Zhang S; Chen S; Qian X; Luo W; Dan Q; Ren Y; Li Y; Zhao B
Acta Pharm Sin B; 2021 Oct; 11(10):3231-3243. PubMed ID: 34729312
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance.
Yang J; Jia Z; Zhang J; Pan X; Wei Y; Ma S; Yang N; Liu Z; Shen Q
Adv Healthc Mater; 2022 Jul; 11(13):e2102799. PubMed ID: 35395704
[TBL] [Abstract][Full Text] [Related]
31. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer.
Qi L; Sun B; Yang B; Lu S
Breast Cancer Res Treat; 2022 Jun; 193(2):305-318. PubMed ID: 35325342
[TBL] [Abstract][Full Text] [Related]
32. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
[TBL] [Abstract][Full Text] [Related]
33. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells.
Wen Y; Chen H; Zhang L; Wu M; Zhang F; Yang D; Shen J; Chen J
Free Radic Biol Med; 2021 Sep; 173():41-51. PubMed ID: 34271106
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
[TBL] [Abstract][Full Text] [Related]
35. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.
Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941
[TBL] [Abstract][Full Text] [Related]
36. Reactive Oxygen Species Amplifier for Apoptosis-Ferroptosis Mediated High-Efficiency Radiosensitization of Tumors.
Wang Z; Ren X; Li Y; Qiu L; Wang D; Liu A; Liang H; Li L; Yang B; Whittaker AK; Liu Z; Jin S; Lin Q; Wang T
ACS Nano; 2024 Apr; 18(14):10288-10301. PubMed ID: 38556985
[TBL] [Abstract][Full Text] [Related]
37. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
[TBL] [Abstract][Full Text] [Related]
38. Natural compound So-2 suppresses triple-negative breast cancer through inducing ferroptosis via downregulating transcription factor E2F7.
Liu N; Jing Z; Wen-Qi D; Ting-Ting L; Cong W; Li-Na H; Feng-Ying Y; Hong-Wei Y; Di G
Arch Biochem Biophys; 2023 Aug; 744():109694. PubMed ID: 37481196
[TBL] [Abstract][Full Text] [Related]
39. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
40. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis.
Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L
J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
